Ilya A. Kofiadi

Moscow, MOW 117513, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Approach to Design of Potent RNA Interference-Based Preparations Against Hepatocellular Carcinoma-Related Genes.

Approach to Design of Potent RNA Interference-Based Preparations Against Hepatocellular Carcinoma-Related Genes.

Journal: International journal of molecular sciences
Published: November 25, 2025

Refined Design and Liquid-Phase Assembly of GalNAc-siRNA Conjugates: Comparative Efficiency Validation in PCSK9 Targeting.

Refined Design and Liquid-Phase Assembly of GalNAc-siRNA Conjugates: Comparative Efficiency Validation in PCSK9 Targeting.

Journal: Molecules (Basel, Switzerland)
Published: November 18, 2025

Neighborhood enrichment for the identification of antigen-specific T-cell receptors.

Neighborhood enrichment for the identification of antigen-specific T-cell receptors.

Journal: Briefings in bioinformatics
Published: May 16, 2025

Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19.

Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19.

Journal: Allergy
Published: November 13, 2024

A Novel Pot-Economy Approach to the Synthesis of Triantennary GalNAc-Oligonucleotide.

A Novel Pot-Economy Approach to the Synthesis of Triantennary GalNAc-Oligonucleotide.

Journal: Molecules (Basel, Switzerland)
Published: November 06, 2024

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®.

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®.

Journal: Vaccines
Published: April 02, 2023

Antiviral Therapy of COVID-19.

Antiviral Therapy of COVID-19.

Journal: International journal of molecular sciences
Published: March 28, 2023

Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation.

Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation.

Journal: Allergy
Published: October 27, 2022

Peculiarities of the T Cell Immune Response in COVID-19.

Peculiarities of the T Cell Immune Response in COVID-19.

Journal: Vaccines
Published: December 07, 2021

Distribution of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 allele frequencies in patients with COVID-19 bilateral pneumonia in Russians, living in the Chelyabinsk region (Russia).

Distribution of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 allele frequencies in patients with COVID-19 bilateral pneumonia in Russians, living in the Chelyabinsk region (Russia).

Journal: Human immunology
Published: November 23, 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 25, 2021

Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia.

Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia.

Journal: Frontiers in immunology
Published: April 19, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026